Summit Global Investments - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,203
+270.3%
336,324
+276.0%
0.35%
+272.0%
Q2 2023$1,405
-99.9%
89,438
-29.7%
0.09%
-40.4%
Q3 2021$2,084,000
+2.9%
127,237
+5.8%
0.16%
+28.9%
Q2 2021$2,025,000
-14.3%
120,310
-7.0%
0.12%
-19.9%
Q1 2021$2,363,000
-35.7%
129,425
-35.9%
0.15%
-58.9%
Q4 2020$3,676,000
+71.2%
202,002
+67.9%
0.37%
+65.3%
Q3 2020$2,147,000
+52.7%
120,322
+53.4%
0.22%
+37.0%
Q2 2020$1,406,00078,4360.16%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders